What is multi-cancer early detection (MCED) testing?

Multi-cancer early detection (MCED) tests:
- Look for signals associated with multiple cancers at once
- Can detect cancer signals even before symptoms appear
- Help find cancers with no traditional screening options
- Are designed to complement standard screenings
- Require follow-up testing after a positive result
Can you detect multiple cancer types with just one blood test? A decade ago, the answer was no. But today, thanks to multi-cancer early detection (MCED) tests, it’s finally possible. So how do these tests actually work? Let’s get into it.
With just a single blood draw, MCED tests look for signals associated with many cancers at once, some can detect more than 50. These early signals can show up in the blood even before symptoms begin — offering a new way to find multiple cancers earlier, when treatment can make the biggest impact
How MCED testing complements traditional screening
MCED testing and traditional screening tests may work differently, but they share the same goal: to find cancer earlier. Standard cancer screening tests look for one type of cancer at a time. A mammogram checks for breast cancer, a colonoscopy looks for colon cancer, a pap smear screens for cervical cancer, and so on.
MCED tests, on the other hand, use a single blood draw to detect signals associated with multiple cancers — including cancers that don’t currently have a traditional screening option (such as pancreatic, ovarian, and liver cancers). This means MCED tests may help find those cancers that otherwise might go undetected until symptoms appear.
That said, MCED tests don’t replace traditional screening tests — they add to them. Mammograms, colonoscopies, and other standard screenings have a strong track record of catching those specific cancers, so it's important to continue following all the recommended guidelines for cancer screening.

How can a blood test help detect cancer?
You may be wondering, can a blood test really help detect cancer? Well, it’s a bit more nuanced than a simple yes or no. MCED blood tests can’t diagnose cancer outright, but they can identify cancer signals before symptoms even start. And to understand how these signals show up in your blood, we first need to dive into a little science.
How MCED tests work
Every cell in your body releases small bits of DNA into your blood. Healthy cells shed normal DNA, but cancer cells shed altered DNA that looks different. They also release unusual proteins and cause changes to DNA methylation, a process that adds small chemical tags to DNA, kind of like switches that help turn certain genes on or off.
MCED tests search for these telltale changes in the blood. Different tests take different approaches, but the Cancerguard test was the first MCED test to analyze both DNA methylation and protein biomarkers, helping it detect cancers that might not be found using either biomarker class alone.
What MCED tests can tell you
MCED tests will indicate whether a potential cancer signal was found in your blood sample. With the Cancerguard test, you’ll receive one of two simple results: “positive” or “negative”. If the Cancerguard test picks up a potential cancer signal, this isn’t a cancer diagnosis — but it does mean follow-up testing is needed. Your doctor will recommend the best next step, which may include imaging or other medical tests.
It's worth noting that some MCED tests include a prediction of which organ a cancer signal originated from, known as tumor of origin. Cancerguard takes a different approach. We recommend imaging scans to diagnose and locate a potential cancer after a positive result. In fact, one modeling study found that this approach was about 30% more efficient than those guided by a tumor of origin prediction. This is especially important when an MCED test gives a positive result but no cancer is present (known as a false positive). In these cases, a tumor of origin prediction could potentially lead to a longer diagnostic journey than starting with imaging.
Which cancer types can MCED tests help detect?
Some current MCED tests, like the Cancerguard test, can detect more than 50 cancer types and subtypes including pancreatic, kidney, lung, colon, ovarian, cervical, and liver cancers.
- Anal
- Bladder and urinary
- Breast*
- Cervical*
- Colon and rectal*
- Esophageal
- Head and neck
- Kidney
- Liver and bile duct
- Lung* and bronchus
- Non-Hodgkin lymphoma
- Ovarian
- Pancreatic
- Prostate*
- Small intestinal
- Stomach
- Testicular
- Thyroid
- Uterine
- Vulvar
*While the Cancerguard test is not specifically indicated for breast or prostate cancer screening, it can detect these and many other cancers. Please continue to follow your doctor’s guidance for colorectal, cervical, breast, and lung (high-risk) cancer screenings, as the Cancerguard test is not a replacement for recommended screenings.
Who should consider MCED testing
Because MCED testing is still a relatively new way to help screen for cancer, there aren't universal guidelines in place for who would benefit most. Still, there’s some general criteria worth keeping in mind. These tests might be a good fit if you’re:
- An adult with a family history of cancer
- Someone with increased cancer risk due to factors like smoking, alcohol use, or obesity
- 50 years and older (risk naturally rises with age)
- Living with known genetic mutations linked to increased cancer risk
- Interested in additional cancer screening options
The best way to find out if MCED testing is right for you? A conversation with your doctor. Be sure to bring up any lifestyle or environmental factors that apply to you — and check out the Cancerguard doctor discussion guide to help get ready for the conversation.
The benefits — and limits — of MCED testing
MCED tests represent a new era of cancer detection — a simple blood test that makes early cancer detection available to more people than ever before. Here are some of the unique strengths of these tests:
- Helps detect multiple cancer types from a single blood draw, making broad, multi-cancer screening not only possible but convenient
- Helps find cancers that don’t currently have routine screening tests, such as pancreatic, ovarian, and liver cancers
- May enable earlier detection of cancer, which could lead to more treatment opportunities and better outcomes
3
That said, it’s important to be aware of the limitations of these tests too. False positives and false negatives can and do occur. A false positive is when a test finds a cancer signal in a blood test, but follow-up tests don’t find cancer. A false negative is when the test doesn't find a signal, but cancer is later found.
And as mentioned, an MCED test also can’t diagnose cancer on its own. Follow-up tests and imaging are needed to confirm and locate a positive result.







